The FDA expanded the marketing indications of a line of diagnostic tests to include checks for Lyme disease—the first cleared by the agency to use a new parallel testing method. Developed by Zeus ...
Testing multiple devices in parallel using the same ATE results in reduced test time and lower costs, but it requires engineering finesse to make it so. Minimizing test measurement variation for each ...
Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2–Activating Mutations: Results From the National Cancer Institute–Molecular Analysis for Therapy Choice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results